diltiazem hydrochloride

Generic: diltiazem hydrochloride extended-release tablets

Labeler: oceanside pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name diltiazem hydrochloride
Generic Name diltiazem hydrochloride extended-release tablets
Labeler oceanside pharmaceuticals
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

diltiazem hydrochloride 360 mg/1

Manufacturer
Oceanside Pharmaceuticals

Identifiers & Regulatory

Product NDC 68682-708
Product ID 68682-708_9c3468f2-1199-4180-9e57-089b5353251a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA021392
Listing Expiration 2026-12-31
Marketing Start 2014-02-06

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68682708
Hyphenated Format 68682-708

Supplemental Identifiers

RxCUI
830874 830877 830879 830882 830897 830900
UNII
OLH94387TE

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name diltiazem hydrochloride (source: ndc)
Generic Name diltiazem hydrochloride extended-release tablets (source: ndc)
Application Number NDA021392 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 360 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-30)
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-90)
source: ndc

Packages (2)

68682-708-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-30) 68682-708-90 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-90)

Ingredients (1)

diltiazem hydrochloride (360 mg/1)

Linked Drug Pages (1)

Diltiazem Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9c3468f2-1199-4180-9e57-089b5353251a", "openfda": {"unii": ["OLH94387TE"], "rxcui": ["830874", "830877", "830879", "830882", "830897", "830900"], "spl_set_id": ["73b3607a-99d0-44d8-92ef-0074684c9d7d"], "manufacturer_name": ["Oceanside Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-30)", "package_ndc": "68682-708-30", "marketing_start_date": "20140206"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-708-90)", "package_ndc": "68682-708-90", "marketing_start_date": "20140206"}], "brand_name": "Diltiazem Hydrochloride", "product_id": "68682-708_9c3468f2-1199-4180-9e57-089b5353251a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "68682-708", "generic_name": "Diltiazem Hydrochloride Extended-Release Tablets", "labeler_name": "Oceanside Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Diltiazem Hydrochloride", "active_ingredients": [{"name": "DILTIAZEM HYDROCHLORIDE", "strength": "360 mg/1"}], "application_number": "NDA021392", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20140206", "listing_expiration_date": "20261231"}